Royal Caribbean Cruises sell BiotechBee
Start price
21.09.22
/
70%
€47.73
Target price
31.12.24
€39.00
Performance (%)
-2.79%
End price
02.01.23
€46.40
Summary
This prediction ended on 02.01.23 with a price of €46.40. With a performance of -2.79%, the SELL prediction for Royal Caribbean Cruises by BiotechBee was down slightly. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Royal Caribbean Cruises | 3.248% | 3.248% | 11.650% | 228.721% |
| iShares Core DAX® | 1,60 % | 5,04 % | 3,87 % | 50,23 % |
| iShares Nasdaq 100 | 3,74 % | 14,95 % | 36,14 % | 101,08 % |
| iShares Nikkei 225® | 3,74 % | 13,89 % | 43,81 % | 69,38 % |
| iShares S&P 500 | 1,82 % | 8,88 % | 25,51 % | 70,97 % |
According to BiotechBee what are the pros and cons of Royal Caribbean Cruises for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Royal Caribbean Cruises diskutieren
Sell mit Kursziel 39,0